Two abortion pill rulings. One uncertain future.
U.S. District Court Judge Matthew Kacsmaryk sided with anti-abortion medical groups that challenged the drug’s federal regulation.
Source: politico.com
📰 Ruth Reader News
Page 3 - Ruth Reader News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ruth Reader. Real-time updates on events, politics, business and more.
A crackdown on 'misleading' Medicare Advantage ads
The Biden administration looks to prohibit insurers from advertising their Medicare Advantage plans in misleading ways.
Source: politico.com
A GOP pro-life agenda shift?
The fall of <i>Roe v. Wade</i> has upended the traditional political battle lines in favor of a new “pro-life” agenda.
New York United States South Carolina Capitol Hill District Of Columbia American Hospital Association
Source: politico.com
The Medicaid expansion holdouts
On Thursday, North Carolina voted to become the 40th state to expand Medicaid.
Source: politico.com
Potential FDA fallout from the mifepristone case
Federal<b> </b>Judge Matthew Kacsmaryk in Texas is expected to make a decision any day now on whether the FDA exceeded its authority in granting accelerated approval to abortion pill mifepristone more than 20 years ago.
Source: politico.com
What's next for CMS - POLITICO
CMS Administrator Chiquita Brooks-LaSure talked with Daniel about strategies she thought were successful to grow enrollment — as well as her “biggest concern” about future enrollment.
Source: politico.com
Biden and the fentanyl hawks
Political pressure has been piling on President Joe Biden to stop the illicit flow of fentanyl across the U.S. border.
Source: politico.com
The FDA's lofty goals - POLITICO
The White House budget request includes plans to strengthen the FDA’s regulatory authority.
Source: politico.com
Insulin pricing takes center stage
Eli Lilly’s announcement that it will cut the list price of Humulin by 70 percent before year’s end was heralded by President Joe Biden.
Source: politico.com